National Institute for Pharmaceutical Technology and Education, Inc.: Single Audit Reports and Findings

National Institute for Pharmaceutical Technology and Education, Inc.'s most recent single audit in the Federal Audit Clearinghouse covers fiscal year 2024, accepted March 6, 2026; the auditor observed on that filing is BWK Rogers PC. It reported 1 finding, including a material weakness. 6 filings from 2016 to 2024 are on record. Data as of 2026-11-06.

Data as of Nov 6, 2026 · Source: Federal Audit Clearinghouse (public data)

Single audits by year

One row per audit year as the Federal Audit Clearinghouse accepted it. The auditor named is the one observed on that filing; National Institute for Pharmaceutical Technology and Education, Inc. is recorded in MINNEAPOLIS, Minnesota under EIN 260636598, and the Clearinghouse records it as a nonprofit. Each report opens on the Clearinghouse itself; how to search the Federal Audit Clearinghouse explains the rest of the reporting package.

Single audits filed by National Institute for Pharmaceutical Technology and Education, Inc.
Audit yearFiscal year endFederal expendedThreshold appliedAuditor observedOpinionFindingsMW / SDFAC report
20242024-06-30$1,703,491$750,000BWK Rogers PCUnmodified1MW2024-06-GSAFAC-0000407202
20202020-06-30$2,040,613$750,000BWK Rogers PCUnmodified0SD2020-06-CENSUS-0000244314
20192019-06-30$2,274,990$750,000BWK Rogers PCUnmodified2MW / SD2019-06-CENSUS-0000244314
20182018-06-30$2,892,448$750,000Abdo, LLPQualified4MW / SD2018-06-CENSUS-0000244314
20172017-06-30$3,350,827$750,000BWK Rogers PCUnmodified2MW / SD2017-06-CENSUS-0000244314
20162016-06-30$1,568,493$750,000BWK Rogers PCUnmodified2MW / SD2016-06-CENSUS-0000244314

When is the next single audit due?

If National Institute for Pharmaceutical Technology and Education, Inc. is again required to have a single audit for the fiscal year ending Jun 30, 2025, the reporting package is due to the Federal Audit Clearinghouse by Mar 30, 2026 at the latest.

No filing for that fiscal year appears in the Clearinghouse data as of Nov 6, 2026. The data does not show why: an organization below the threshold is not required to file, and a filing can be accepted after the due date.

Whether an audit is required depends on federal awards expended in that year (the single audit threshold). The rule, 2 CFR 200.512(a): the reporting package is due within 30 calendar days after the auditee receives the auditor's report or nine months after the end of the audit period, whichever is earlier; the date above is the nine-month date, moved to Monday when it falls on a weekend. Last verified: 2026-11-15.

Which federal programs did this organization report?

From the most recent accepted report, as listed on its schedule of expenditures of federal awards (SEFA). "Major" is the designation the auditor made under 2 CFR 200.518, not ours.

Federal programs on the most recent report
ALNProgramExpendedMajor
93.103Food and Drug Administration Research$944,442Yes
93.103Food and Drug Administration Research$712,681Yes
47.041Engineering$46,368No

What findings did the auditor report?

The reference is the auditor’s; the requirement is the Compliance Supplement category the auditor selected. The finding text itself is not reproduced here; the FAC report linked above carries it in full. What the two severity levels mean: material weakness vs significant deficiency.

Findings on the most recent report
ReferenceRequirementSeverityRepeat
2024-003Reporting (L)Material weaknessNo

Form 990 and IRS registration

Form 990 "accounting fees" (Part IX line 11c) cover all accounting services reported by the organization and are not the price of an audit engagement.

Where to find the return itself, and what our Form 990 data covers: Form 990 lookup.

Total revenue
$3,485,704
Total assets
$4,763,244
IRS object id
202621359349305812
NTEE code
T12
Exempt under
501(c)(3)
Ruling year
2008
BMF release
2026-10-20

Read next

How we computed this

Every row comes from the Federal Audit Clearinghouse record named beside it, one report per audit year, with a resubmission superseding the filing it replaces. The auditor is the one named on that filing — it is not a statement about who audits National Institute for Pharmaceutical Technology and Education, Inc. now. Form 990 figures come from the IRS e-filed return named by its object id. This page exists because the organization filed at least two single audits, or one with a finding.

Cite this page

AuditRadar. “National Institute for Pharmaceutical Single Audit FY2024 (MN).” https://getauditradar.com/single-audits/mn/national-institute-for-pharmaceutical-technology-and-education-inc-260636598/. Data as of 2026-11-06.